Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Chi

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Neuro-Oncology Practice|March 5, 2021
Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual diseaseShannon E Fogh, Lauren Boreta, Jean L Nakamura, et al.
Oncotarget|November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastomaIsabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2017
Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M-Mutant Leptomeningeal Lung AdenocarcinomaChristine Cordova, Andrew S Chi, Abraham Chachoua, et al.
Skeletal Radiology|August 12, 2015
Prevalence and pattern of gluteus medius and minimus tendon pathology and muscle atrophy in older individuals using MRIAndrew S Chi, Suzanne S Long, Adam C Zoga, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2014
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinibJustin F Gainor, Carol A Sherman, Kathryn Willoughby, et al.
Molecular and Cellular Biology|February 7, 2007
Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiationXianyong Ma, Matthew J Renda, Lin Wang, et al.
Plos Genetics|December 21, 2010
GC-rich sequence elements recruit PRC2 in mammalian ES cellsEric M Mendenhall, Richard P Koche, Thanh Truong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose AlectinibJustin F Gainor, Andrew S Chi, Jennifer Logan, et al.
Cardiovascular and Interventional Radiology|June 26, 2019
Assessing the Need for Preprocedural Laboratory Tests and Stopping Non-steroidal Anti-inflammatory Drugs/Aspirin in Patients Undergoing Percutaneous Bone and Soft Tissue BiopsiesSamir D Mehta, Kristy Weber, Lee Fleisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adultsAndrew S Chi, Tracy T Batchelor, Daniel Yang, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Neuro-Oncology Practice|March 5, 2021
Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual diseaseShannon E Fogh, Lauren Boreta, Jean L Nakamura, et al.
Oncotarget|November 8, 2017
A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastomaIsabel Arrillaga-Romany, Andrew S Chi, Joshua E Allen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2017
Osimertinib Dose Escalation Induces Regression of Progressive EGFR T790M-Mutant Leptomeningeal Lung AdenocarcinomaChristine Cordova, Andrew S Chi, Abraham Chachoua, et al.
Skeletal Radiology|August 12, 2015
Prevalence and pattern of gluteus medius and minimus tendon pathology and muscle atrophy in older individuals using MRIAndrew S Chi, Suzanne S Long, Adam C Zoga, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2014
Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinibJustin F Gainor, Carol A Sherman, Kathryn Willoughby, et al.
Molecular and Cellular Biology|February 7, 2007
Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiationXianyong Ma, Matthew J Renda, Lin Wang, et al.
Plos Genetics|December 21, 2010
GC-rich sequence elements recruit PRC2 in mammalian ES cellsEric M Mendenhall, Richard P Koche, Thanh Truong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose AlectinibJustin F Gainor, Andrew S Chi, Jennifer Logan, et al.
Cardiovascular and Interventional Radiology|June 26, 2019
Assessing the Need for Preprocedural Laboratory Tests and Stopping Non-steroidal Anti-inflammatory Drugs/Aspirin in Patients Undergoing Percutaneous Bone and Soft Tissue BiopsiesSamir D Mehta, Kristy Weber, Lee Fleisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2013
BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adultsAndrew S Chi, Tracy T Batchelor, Daniel Yang, et al.
Pageof 9